Intravitreal Anti Vascular Endothelial Growth Factor Agents in The Management of Retinal Diseases: An Audit

PURPOSE: The study aimed to describe our initial experience with the use of anti vascular endothelial growth factors (anti-VEGFs) in the treatment of retinal diseases. METHODS: The case records of all patients who had received at least 3 doses of intravitreal anti- VEGF injections between January 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiebai, Bassey, Odogu, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725526/
https://www.ncbi.nlm.nih.gov/pubmed/29299078
http://dx.doi.org/10.2174/1874364101711010315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725526/
https://www.ncbi.nlm.nih.gov/pubmed/29299078
http://dx.doi.org/10.2174/1874364101711010315

Ejemplares similares